Bellevue Group’s BELLUS Health Inc. BLU Stock Holding History

Bellevue Group’s Portfolio BLU Stock Details BLU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-44,905	Closed	-$369K	–	176
2022 Q4	$369K	Buy	+44,905	New	+$419K	﹤0.01%	153

Other funds holding BLU

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Power Corp of Canada Montreal, Quebec, Canada $745M AUM 22.7% 1-Year Est. Return

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bellevue Group's BLU Position: Q1 2023 in Review

Bellevue Group sold out of BELLUS Health Inc. (BLU) in Q1 2023, closing a stake of 44,905 shares — an estimated $369K sold.

Bellevue Group first reported a position in BLU in Q4 2022 and held it in 1 quarter. The position peaked at $369K in Q4 2022. 106 funds tracked by Wall St. Rank hold BLU as of Q1 2023.

Bellevue Group reported no remaining BELLUS Health Inc. position as of Q1 2023 after selling out during the quarter.
Bellevue Group sold 44,905 BELLUS Health Inc. shares in Q1 2023, an estimated $369K.
Bellevue Group first reported a position in BELLUS Health Inc. in Q4 2022 and held it in 1 quarter.
Bellevue Group's BELLUS Health Inc. position peaked at $369K in Q4 2022.
106 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q1 2023.

Based on Bellevue Group's 13F filing for Q1 2023, filed 15 May 2023.